Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

quinocarmycin citrate

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
A novel antitumor antibiotic, 2«,3,4,5,6,6a,7,lIA-octahydro-lI-niethoxy-12-methyl-3,6-imino-l//-2-oxa-llc-azanaphth(l,2,3-c… Expand
  • figure 1
  • table 1
  • table 3
  • table 4
  • figure 2
2004
2004
SummaryThe effects of the antitumor antobiotic, quinocarmycin citrate (KW 2152), on L1210 cells were studied in vitro. The… Expand
  • figure 1
  • figure 2
  • figure 3
1995
1995
Quinocarmycin monicitrate (KW2152) and its analogue, DX-52-1, demonstrated specificity for melanomas in the National Cancer… Expand
1988
1988
Growth inhibitory activity of quinocarmycin citrate (KW2152) against 25 human cultured cell lines derived from leukemias and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
1988
1988
The antitumor spectra of quinocarmycin citrate (KW-2152; QCM), a novel antibiotic with a different molecular structure from… Expand
1987
1987
A novel antitumor antibiotic, 2a,3,4,5,6,6a,7,11b-octahydro-11-methoxy-12-methyl-3,6-imino-1H-2-oxa-11 c- azanaphth(1,2,3-cd… Expand
1987
1987
Quinocarmycin monocitrate is a novel antitumor antibiotic isolated from Streptomyces melanovinaceus. We have utilized a human… Expand